About the
NeLM
|
Help & Support
|
Site Feedback
|
Update Newsletter Subscription
Homepage
Login
|
Register
Search the NeLM
Medicines A-Z
Find key information about medicines by name (prototype)
Browse by Categories:
BNF Category
|
Medical Specialty
|
National Health Service
|
Medicines Information
Browse by NeLM area:
Evidence
|
Other Library Updates
|
News
|
Health In Focus
|
Medicines A-Z
|
Communities
|
Useful Links
|
Formularies
Medical Specialty
Anaesthesia
Bone Diseases
Cardiovascular Medicine
Care of Older People
Cerebrovascular Disorders
Complementary Medicine
Dentistry
Dermatology
Ear, Nose and Throat (ENT) disorders
Emergency Medicine
Endocrinology
Family planning
Gastroenterology
Geriatric Medicine
Haematology
Immunology and vaccination
Infections
Infectious Diseases
Intensive Care (ICU)
Liver disease
Menopause / hormone replacement therapy (HRT)
Mental Health
Neurology
Nutrition and Metabolism
Obstetrics & Gynaecology
Oncology
Ophthalmology
Paediatrics
Pain control
Palliative care
Preventative medicines
Radiology
Renal medicine
Reproductive medicine
Respiratory Medicine
Rheumatology
Sports medicine
Surgery
Travel medicine
Urology
Wound Management
Arrhythmias
Cardiomyopathy
Circulatory Disorders
Congenital heart disease
Heart Failure
Hyperlipidaemia
Hypertension
Ischaemic heart disease
Valvar diseases
Venous Thromboembolism
405 library items
in Hyperlipidaemia
Filter results by:
Date Published
2012 (4)
2011 (79)
2010 (63)
2009 (66)
2008 (56)
More
NeLM
Area
News
Other Library Updates
Health In Focus
Evidence
Medicines A-Z
Communities
Formularies
Results filtered by:
Category
Cardiovascular Medicine (
remove
)
,
Hyperlipidaemia (
remove
)
Sort by:
Least recent publication date
Most recent publication date
Title alphabetical A-Z
Title alphabetical Z-A
Source alphabetical A-Z
Source alphabetical Z-A
Display summary:
No
Yes
Results 1 - 10 of 405
Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next
1.
Effects of n-3 fatty acids on major cardiovascular events in statin users and non-users with a history of myocardial infarction
Source:
Eur Heart J
,
Date published:
02/02/2012
Category:
2.12 Lipid-regulating drugs
|
Hyperlipidaemia
|
Myocardial Infarction
NeLM
Area:
News
Abstract
2.
Meta-analysis of statin effects in women versus men
Source:
J Am Coll Cardiol
,
Date published:
02/02/2012
Category:
2.12 Lipid-regulating drugs
|
Hyperlipidaemia
NeLM
Area:
News
Abstract
3.
FDA approves updated label but not new indication for Vytorin®(ezetimibe/simvastatin) to incorporate data from SHARP
Source:
BioSpace , Reuters Health News
,
Date published:
26/01/2012
Category:
2.12 Lipid-regulating drugs
|
Food &Drug Administration (FDA)
|
Hyperlipidaemia
|
Product Licence Changes
|
Renal medicine
NeLM
Area:
News
Link to BioSpace story
Link to Reuters story- subscribers only
4.
AWMSG issues Final Appraisal Recommendation on rosuvastatin (Crestor®)
Source:
All Wales Medicines Strategy Group (AWMSG)
,
Date published:
19/01/2012
Category:
2.12 Lipid-regulating drugs
|
All Wales Medicines Strategy Group (AWMSG)
|
Drug reviews
|
Hyperlipidaemia
NeLM
Area:
Evidence
>
Drug Specific Reviews
Link
5.
Commentary: Screening and drug treatment of dyslipidaemia in children and adolescents
Source:
JAMA
,
Date published:
20/12/2011
Category:
2.12 Lipid-regulating drugs
|
Drugs in paediatrics
|
Hyperlipidaemia
|
Paediatrics
NeLM
Area:
News
Full text article
6.
Lipitor 5mg, 10mg, 20mg, 40mg chewable tablets (atorvastatin calcium trihydrate)- New product
Source:
eMC (electronic Medicines Compendium)
,
Date published:
01/12/2011
Category:
2.12 Lipid-regulating drugs
|
Hyperlipidaemia
|
Product Licence Changes
NeLM
Area:
Other Library Updates
>
SPC Changes
SPC
7.
Results of systematic review and meta-analysis do not support role of statins in infection prevention
Source:
British Medical Journal
,
Date published:
30/11/2011
Category:
2.12 Lipid-regulating drugs
|
Hyperlipidaemia
|
Infections
NeLM
Area:
News
Link
Editorial
8.
Extended follow-up of the statin Heart Protection Study published
Source:
Lancet
,
Date published:
23/11/2011
Category:
2.12 Lipid-regulating drugs
|
Hyperlipidaemia
NeLM
Area:
News
Link (abstract)
Comment
9.
MHRA Drug Safety Update: Yellow cards which have made a difference – high dose rosuvastatin associated with increased risk of rhabdomyolysis
Source:
MHRA
,
Date published:
17/11/2011
Category:
2.12 Lipid-regulating drugs
|
Adverse Drug Reactions
|
Hyperlipidaemia
|
Medicines and Healthcare products Regulatory Agency (MHRA)
NeLM
Area:
Evidence
>
Medication Safety
Link
10.
Horizon scanning: Evacetrapib monotherapy or in combination with statins on HDL and LDL cholesterol
Source:
JAMA
,
Date published:
16/11/2011
Category:
2.12 Lipid-regulating drugs
|
Hyperlipidaemia
|
New drugs
NeLM
Area:
News
Abstract
Editorial
Results 1 - 10 of 405
Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next